EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Simply Solventless Concentrates Ltd. (HASH) fair value: what the stock is really worth

We calculate from audited financials what Simply Solventless Concentrates Ltd. is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 25, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Healthcare · CA

SS Thin data Jun 25, 2026

Simply Solventless Concentrates Ltd.

HASH · V

Weakest SetupStrongly overvalued and low quality.

!Fair value C$0.0292 · Strongly overvalued (−42%)
!Quality 21/100
!Mixed Growth (revenue 3y +124.0 %/yr)
✓Highly profitable · 28.0% net margin (TTM)
!negative free cash flow
✓Ranks above peers (7/10)
!Moderate moat 63/100
!Evidence only low, so the estimate is less certain
Watch Simply Solventless Concentrates Ltd. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

C$0.8100 C$0.0350 Fair Value C$0.0292 Dec 2023 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 25, 2026.

How to read this chart

33‑month range C$0.0350 – C$0.8100 · fair‑value band C$0.0219 – C$0.0365 · the C$0.0500 price screens above the C$0.0292 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jun 25, 2026.

Follow Simply Solventless Concentrates in your weekly email

Every Wednesday you see whether Simply Solventless Concentrates is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada. The company was incorporated in 2020 and is based in Calgary, Canada.

Stock analysis

Simply Solventless Concentrates Ltd. (HASH) currently trades at C$0.0500, while our model-based Fair Value estimate is C$0.0292, implying the stock looks roughly 71.2% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 87/100, which puts the evidence level at low.

Scenario range: C$0.0219 (bear) to C$0.0365 (bull), the price of C$0.0500 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Simply Solventless Concentrates Ltd. reported revenue of C$13.7M in FY2024 versus C$1.2M in FY2021, a compound +124.0%/yr. Reported net income was −C$5.2M in FY2024.

Key figures

Market cap C$5.4M (≈ $3.8M) · P/E ratio 0.8 · P/S ratio 0.12 · EPS (TTM) C$0.0600 · Net margin −38.0% · Return on equity 41.8% · Return on assets (EBIT) −17.4% · Operating margin 0.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).

What moves the price

The share trades about 83% below its 52-week high and 43% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at −42%, HASH screens richer than that median.

Fair Value models

Bear C$0.0219 Fair Value C$0.0292 Bull C$0.0365
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2024 figures (about 12 months old). Earnings retained since then (C$0.0600 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) C$0.0700 C$0.0900 C$0.1300 52
All 1 models by family
Asset-Based
NCAV (Graham) C$0.0700 C$0.0900 C$0.1300 52

Open the full fair value analysis →

Notify me when HASH reaches fair value

Put HASH on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 21/100

Of which business quality 20 · Market factors (momentum, volatility) 38

Profitability 5
Margins and returns on capital today
Quality Growth 25
Are margins and returns improving?
Cashflow 14
Earnings quality: real cash, not paper profit
Fin. Strength 43
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 60/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+120.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+124.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−191.0% (2021) → −29.9% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
not computed

HASH screens 71% overvalued. Compare with Merck KGaA →

Compare Simply Solventless Concentrates Ltd. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 630 stocks

Beats the industry median on 7/10 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 20 · Bottom 25%
Fair Value upside −42% · Below median
Profitability
Return on equity (TTM) 42% · Top 25%
Return on assets 6% · Above median
Net margin (TTM) 28% · Top 25%
Operating margin (TTM) 1% · Below median
Growth and dividend
Revenue growth 56% · Top 25%

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/E (TTM) 0.8× · Cheapest 25%
P/B 0.25× · Cheapest 25%
P/S (TTM) 0.11× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 14
FUTURE (revenue growth)100 · sector 20
PAST (return on equity)100 · sector 27
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 32

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €133.95 €108.70 −19%
Takeda Pharmaceutical Company TAK $18.81 $11.29 −40%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥45.58 ¥50.14 +10%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,865 ₹1,979 +6%
Galderma Group GALD CHF 163.80 CHF 109.88 −33%
Haleon plc HLN $9.25 $8.50 −8%
Teva Pharmaceutical Industries Limited TEVA $39.01 $20.75 −47%
Sandoz Group SDZ CHF 70.76 CHF 40.16 −43%
Zoetis Inc ZTS $71.61 $108.48 +51%
Hansoh Pharmaceutical Group 3692 HK$35.34 HK$38.87 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Simply Solventless Concentrates Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/HASH

Frequently asked questions

Is Simply Solventless Concentrates Ltd. (HASH) overvalued or undervalued?
As of Jun 25, 2026, our model estimates a fair value of C$0.0292 versus a price of C$0.0500, about −42% upside (overvalued).
What is the fair value of HASH?
Our model-based fair value for Simply Solventless Concentrates Ltd. is C$0.0292 (as of Jun 25, 2026), built from audited fundamentals. The current price: C$0.0500.
What is the quality score of HASH?
Simply Solventless Concentrates Ltd. has a Quality Score of 21/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Simply Solventless Concentrates Ltd. (HASH)?
Our model-based price target is the fair value of C$0.0292 (as of Jun 25, 2026) from 1 valuation models. Cautious scenario C$0.0219, optimistic scenario C$0.0365. It is a calculation from audited fundamentals, not an analyst target.
What is the Simply Solventless Concentrates Ltd. stock forecast for 2026?
Our models put fair value at C$0.0292, about −42% upside versus a price of C$0.0500 (overvalued). Cautious scenario C$0.0219, optimistic scenario C$0.0365. The calculation is refreshed regularly with new filings.
What is the revenue of Simply Solventless Concentrates Ltd. (HASH)?
Simply Solventless Concentrates Ltd. reported trailing-twelve-month revenue of about C$33.7M (latest available figure, as of Jun 25, 2026).
What is the intrinsic value of Simply Solventless Concentrates Ltd. (HASH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Simply Solventless Concentrates Ltd. it is C$0.0292 per share (as of Jun 25, 2026), against a price of C$0.0500. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Simply Solventless Concentrates Ltd. stock overvalued or undervalued in 2026?
As of Jun 25, 2026, HASH trades above its calculated fair value: price C$0.0500, fair value C$0.0292, a gap of about −42% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of HASH?
No. The price is what the market pays today (C$0.0500); the fair value is what the company's own numbers justify (C$0.0292). For Simply Solventless Concentrates Ltd. the two are C$0.0208 per share apart. That gap is exactly why we show both numbers side by side.
How much is Simply Solventless Concentrates Ltd. worth?
The market values Simply Solventless Concentrates Ltd. at about C$5.4M (market capitalisation, as of Jun 25, 2026). Per share that is C$0.0500; our models calculate a fair value of C$0.0292 per share.
What do the bullish and bearish scenarios say about HASH?
Our models span a range for Simply Solventless Concentrates Ltd.: cautious scenario C$0.0219, base C$0.0292, optimistic C$0.0365 per share (as of Jun 25, 2026, price C$0.0500). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of HASH?
Simply Solventless Concentrates Ltd. trades at a price-to-earnings ratio of 0.8 (as of Jun 25, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of C$0.0292 is built from several models across several years. Other multiples: P/B 0.3, P/S 0.1.
How solid is the balance sheet of Simply Solventless Concentrates Ltd. (HASH)?
Balance-sheet figures for Simply Solventless Concentrates Ltd. (as of Jun 25, 2026): return on equity 41.8%. They feed the Quality Score of 21/100, which measures business quality independently of the share price.
How far is HASH from its 52-week high?
Simply Solventless Concentrates Ltd. trades at C$0.0500, about 83% below its 52-week high of C$0.2900 and 43% above the low of C$0.0350 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of C$0.0292 is for.
Which stocks are comparable to Simply Solventless Concentrates Ltd.?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Simply Solventless Concentrates Ltd. stock attractive at the current price?
The data as of Jun 25, 2026: price C$0.0500, calculated fair value C$0.0292 (−42%), Quality Score 21/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of HASH calculated?
We run Simply Solventless Concentrates Ltd. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of C$0.0292, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Simply Solventless Concentrates Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Simply Solventless Concentrates Ltd. (HASH)?
The closing price on Sep 23, 2026 was C$0.0500. Our model-based fair value is C$0.0292, about −42% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Simply Solventless Concentrates Ltd. right now?
The price sits above even our optimistic bull case (C$0.0365). The favourable scenario is already priced in. Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Simply Solventless Concentrates Ltd.

How large is the market capitalisation of Simply Solventless Concentrates Ltd. (HASH)?
The market capitalisation of Simply Solventless Concentrates Ltd. is C$5.4M (≈ $3.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Simply Solventless Concentrates Ltd. (HASH)?
The price-to-sales ratio of Simply Solventless Concentrates Ltd. is 0.12 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Simply Solventless Concentrates Ltd. (HASH)?
Earnings per share at Simply Solventless Concentrates Ltd. are C$0.0600 (price ÷ EPS = P/E 0.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Simply Solventless Concentrates Ltd. (HASH)?
The net margin of Simply Solventless Concentrates Ltd. is −38.0% (fiscal year 2024). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Simply Solventless Concentrates Ltd. (HASH)?
The return on equity (ROE) of Simply Solventless Concentrates Ltd. is 41.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Simply Solventless Concentrates Ltd. (HASH)?
On an EBIT basis the return on assets of Simply Solventless Concentrates Ltd. is −17.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Simply Solventless Concentrates Ltd. (HASH)?
The operating margin of Simply Solventless Concentrates Ltd. is 0.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Simply Solventless Concentrates Ltd. (HASH)?
Revenue at Simply Solventless Concentrates Ltd. is growing +55.7% versus a year earlier (3y avg +124%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Simply Solventless Concentrates Ltd. (HASH)?
Earnings per share at Simply Solventless Concentrates Ltd. are growing +590% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Simply Solventless Concentrates Ltd. (HASH) generate?
The free cash flow of Simply Solventless Concentrates Ltd. is −C$6.2M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Simply Solventless Concentrates Ltd. (HASH) carry?
The net debt of Simply Solventless Concentrates Ltd. is C$6.2M (fiscal year 2024). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Simply Solventless Concentrates Ltd. in the live analysis

One click puts Simply Solventless Concentrates Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.